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Abstract
Background: Neuronal communication is tightly regulated in time and in space. The neuronal
transmission takes place in the nerve terminal, at a specialized structure called the synapse.
Following neuronal activation, an electrical signal triggers neurotransmitter (NT) release at the
active zone. The process starts by the signal reaching the synapse followed by a fusion of the
synaptic vesicle and diffusion of the released NT in the synaptic cleft; the NT then binds to the
appropriate receptor, and as a result, a potential change at the target cell membrane is induced.
The entire process lasts for only a fraction of a millisecond. An essential property of the synapse is
its capacity to undergo biochemical and morphological changes, a phenomenon that is referred to
as synaptic plasticity.
Results: In this survey, we consider the mammalian brain synapse as our model. We take a cell
biological and a molecular perspective to present fundamental properties of the synapse:(i) the
accurate and efficient delivery of organelles and material to and from the synapse; (ii) the
coordination of gene expression that underlies a particular NT phenotype; (iii) the induction of
local protein expression in a subset of stimulated synapses. We describe the computational facet
and the formulation of the problem for each of these topics.
Conclusion: Predicting the behavior of a synapse under changing conditions must incorporate
genomics and proteomics information with new approaches in computational biology.
Introduction
The structure and function of the synapse has been the
topic of extensive research for many decades [1-5]. It is
only in recent years that the molecular complexity of this
structure has been fully appreciated. The availability of
complete genomes throughout the evolutionary tree
raised new avenues to address the link between the mole-
cules that are involved in the structural organization of the
synapse and its functionality [6-8].
Computational Neuroscience
Most research in the field of computational neuroscience
can be viewed in a 'systems biology' perspective, meaning
that each of the neurons is considered to be an integrator
device and a major goal is to understand the behavior of
the neuronal network. For such a task, strong theoretical
tools, combined with experimental measurements,
proved to be essential. Still, due to the inherent complex-
ity of the mammalian CNS, much of the research in this
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invertebrates [9-11]. A desirable goal is to develop a sim-
ulator that will accurately predict neuronal network prop-
erties (such as synchronization, rhythm, robustness). Of
course, a key component in building such a computa-
tional scheme is to incorporate the biochemical and bio-
physical properties of the neuron. Fortunately, accurate
techniques were developed over the years that allow direct
measurements of neurons in-vivo and in-vitro with high
spatial and temporal resolution, including subcellular res-
olution imaging of Ca2+ dynamics, electrophysiological
measurements of a single ion channel and more.
As a result of the sequencing of the human genome and
the genomes of hundreds of other organisms, many
genomics and proteomics databases and tools that are
specific to the field of neuroscience are becoming availa-
ble [12-15]. The outcome of recent large-scale genomics
and proteomics measurements (i.e. DNA-, Protein- and
Cell-Arrays) is a quantitative view on the quantities, sub-
types, interactions and modifications of all components
in the cell, including molecules that determine neuronal
functionality (such as ion channels, transporters, recep-
tors, and protein kinases). Additional technologies that
complement the above data are time-lapse subcellular vis-
ualization techniques and systematic genetic intervention
(i.e., RNAi screen, [16]). It is expected that when all these
data sources are integrated at the cellular level, the con-
struction of an accurate quantitative model of a functional
neuronal network becomes feasible. A long term applica-
tion for these powerful techniques is in deciphering the
molecular basis of neurological and mental diseases [17].
Having briefly described some of the development in the
field of genomics and proteomics, we would like to go
back to the functional synapse. A functional synapse can
be described in terms of its expressed molecular informa-
tion (i.e., transcripts, proteins). This paper aims to cover
few selected topics in cellular neuroscience. In order to
appreciate the context, we provide the elementary back-
ground needed to understand the functionality of the syn-
apse. We choose to address three different aspects related
to a mature CNS synapse: (i) the principles underlying
organized delivery of material in the axons; (ii) the coor-
dinated expression of functionally related genes; and (iii)
trafficking and translational control outside of the cell
body. For each of the topics, we will touch upon the com-
putational biology questions that arise and propose
potential directions to address these questions. Due to the
space constrains, we mostly cite review articles rather than
primary sources, and we limit our discussion to the level
of a single synapse.
Neuron anatomy and physiology
For a brief introduction to nerve cell anatomy, we recall
the following facts and principles of a neuron's anatomy.
The mammalian central nerve system (CNS) is made up of
a hundred billions nerve cells. Typically, a neuron con-
tains (i) a central cell body that directs all activities of the
neuron; (ii) dendrites that receive messages from other
neurons and relay them to the cell body; (iii) an axon, a
long fiber that transmits messages from the cell body to
the dendrites of neighboring neurons. The synapses of the
CNS and those of the peripheral nerve system share many
anatomical and functional features. Yet, they are markedly
different in their plasticity. For simplicity, we will focus on
a prototype mammalian CNS synapse as our model.
The communication between nerve cells is based on the
detailed structures and organization of the transmitting
axon and of the receiver dendrite. These structures and the
space between them comprise the synapse. According to
the directionality of the transmission, the axon terminal is
denoted as the presynaptic site while the dendrite com-
prises the postsynaptic site [1,18,19]. When neurons com-
municate, an electrical impulse propagates down the axon
and toward the synapse. There, following depolarization
and influx of Ca2+, synaptic vesicles (SVs) are fused, result-
ing in a release of NT to the synaptic cleft. The NT diffuses
across the synaptic cleft and binds to the appropriate NT
receptors that are located within the postsynaptic mem-
branes of the adjacent cell. This, in turn, stimulates (or
inhibits) an electrical response. The presynaptic site is rap-
idly recovers, i.e., SVs are recycled and refilled. This
sequence of events define a basic functional step of any
synapse.
A. The Neuronal Anatomy
Many properties of neuronal function are attributed to the
cell's anatomy. Neuronal anatomy is tightly linked to the
inherent polarity of neurons. We will not discuss the
mechanism underlying the establishment of cell polarity
[20,21]. However, we will dwell on the difficulty of main-
taining and supporting a cell with such an extreme polar-
ity. In most neurons, the axon that extends from the cell
body is very far from the site of synapse, where NT release
takes place: while the size of an average synapse is only a
few microns, the neuronal cell body may be as far as one
meter or more from its nerve terminal. While electrical
information can be transferred through the membrane
very quickly, this is not the case for the chemicals, pro-
teins, membranes and organelles that are to be shipped
back and forth between the cell body and the nerve termi-
nal. The cell body must constantly supply new materials
to the synapse. This includes proteins for NT storage, met-
abolic enzymes for NT production or its breakdown, resi-
dent proteins of SVs, regulators of exo- and endocytosis,Page 2 of 9
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more.
Protein translation, peptide and hormone storage and for-
mation of new membranes are carried out in the cell body
(and to some extend also in the dendrites, see section C).
As no local protein production is possible in nerve termi-
nals, all material must be coordinately transported. The
anatomical difficulty has to be resolved as the synapse
must respond to signals from its surrounding, and to mes-
sages coming from the cell body.
What are the cellular and molecular strategies that are
adopted by the neuron for an efficient and accurate deliv-
ery between the two remote subcellular entities? Transport
of membranes, organelles and proteins to the synapse is
referred to as axonal transport. Extensive studies of axonal
transport shed light on its molecular basis: the microtu-
bules (MT) are the 'freeways' on which the molecular
motors act as vehicles that deliver their cargo. Note that a
retrograde transport from the nerve terminal to the cell
body also exists. The fundamental properties of axonal
transport are as follows: (i) energy drives the process; (ii)
the tracks for movement are the axonal MT; (iii) move-
ment is accomplished by a family of motor proteins called
kinesins; (iv) most material is delivered by transport vesi-
cles. Similar principles for MT dependent movements are
found outside of the nerve system [22].
Kinesin molecules show a large variation in their biophys-
ical properties. Nevertheless, a generic member of kinesin
is composed of a motor domain that provides the move-
ment, a connector domain that determines the properties
and directionality of the movement elementary step, and
a tail domain that is in charge of the specificity to the
transported cargo (Fig. 1). Based on sequencing and on
the annotation of the human and some rodent genomes,
it becomes clear that the molecular complexity of the
kinesin family is higher than anticipated [23-25]. The 41
predicted sequences in the human genome (48 in the
mouse genome) are classified into 14 subfamilies with
some additional orphan members [26]. Most kinesins are
similar in their domain organization. Experimental evi-
dences suggest the each kinesin provides its own unique-
ness in term of the biophysical properties (i.e speed,
efficiency, step size and association with the MT track)
and the specificity toward the cargo [27]. For example, a
particular kinesin transports mitochondria while a closely
related member is associates with SV transport.
From the biological perspective, the issue of specificity
and redundancy among the 48 kinesins in the mouse
genome is still open. The hypothesis that the number of
kinesin molecules and their composition on a transport
vesicle deterministically define the capacity of the neuron
to replenish the synapse remains to be tested. The specifi-
city of the different kinesins cannot be based on lipid rec-
ognition but rather on a very specific interaction with
adaptor proteins and with membrane associated recogni-
tion complexes (Fig. 1). The confirmation that an inter-
mediate molecule links a kinesin motor to its cargo vesicle
allows a richer combinatorial 'mix and match' strategy for
transport. Indeed, it was shown that KIF5, with the help of
linker molecules, participates in the transport of mito-
chondria, APP (amyloid precursor protein) rich vesicle,
RNA-containing granules and more. In this case, a set of
specific adaptors also dictates the participation of KIF5 in
transport to dendrites or to nerve terminals (see section
C).
Kinesin based pull-down experiments combined with
high coverage mass spectrometry identification is
expected to decipher the complexity of the transport mol-
ecules and to assess the importance of post-translational
A scheme for kinesin attached to mictotubules (MT) and to a ve iclFigure 1
A scheme for kinesin attached to mictotubules (MT) and to a 
vesicle. The molecule is composed of two heads (marked by 
an arrow) that allow attachment to MT, a central coiled 
region and a region which connects the molecule to the 
intracellular vesicle to be moved. The movement is based on 
ATP hydrolysis by the head motor domain. Adaptor and 
receptors associated with the cargo vesicles (SV, synaptic 
vesicle; Mito, mitochondria; APP, Amyloid precursor protein) 
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actions. A complementary computational effort may rely
on sequence-based comparative studies. A sequence-
based analysis for identifying simple signatures in the
transported proteins for kinesins was not successful [28].
The plant A. thaliana exhibits unexpected complexity in
term of motor proteins (of course, plants lack neurons).
The A. thaliana genome contains as many as 61 kinesins,
many of which are still orphan, with no information
regarding their movement directionality or their cargo
specificity. On the other hand, the sequences of fly, bee,
worm, zebrafish, chicken, rodents and other mammalian
genomes are already completed. The neuro-anatomical
and axonal transport properties in all these organisms are
very similar. Consequently, a multiple alignment of the
kinesin recognition sequences matched with their trans-
ported protein homologues can be used as a basis for
defining the key elements in the cargo recognition. A
more restricted goal is to classify all kinesins by their rec-
ognition preferences. In recent years, machine learning
tools were successfully applied in very similar tasks for
predicting protein-DNA, protein-protein and protein-
small ligand interaction rules, so this program seems
promising for the study of axonal transport. From experi-
mental point of view, testing the ability of engineered chi-
meric kinesins to deliver specific cargo is critical for
discovering specificity rules in axonal delivery.
B. Neurotransmitter Phenotype Specificity
Neurons in the CNS are characterized by their "phenotype",
defined as the property of the synapse for releasing a spe-
cific NT. Each phenotype is associated with a set of pro-
teins that are unique for that NT [29-31]. All the NT
phenotype proteins must be fully active at the vicinity of
the synapse and thus must be efficiently delivered by fast
axonal transport (section A) or by a receptor delivery
mechanism at the postsynaptic site [32]. Neurons typi-
cally release one specific NT but may respond to a variety
of other NTs and modulators. The different site of action
for each of the NT-specific molecules is shown in the sche-
matic representation of a synapse (Fig. 2). Each NT can
only bind to its cognate receptor types that are located at
the postsynaptic membrane (Fig. 2A). It is this specific
binding that induces activation of the target cell. Further-
more, binding of NT to auto-inhibitory receptors local-
ized at the presynaptic site control the NT release of that
synapse (Fig 2B). Once the released NT binds to its appro-
priate receptors, it is inactivated and removed either by an
enzymatic reaction that breaks down the NT (Fig. 2C) or
by NT transporters with high selectivity and high capacity
that ensures the uptake of the NT back to the presynaptic
site. For example, breaking down acetylcholine (ACh)
into choline and acetate is carried out by the potent
enzyme (acetylcholinesterase, AChE) that resides at the
synaptic cleft. A high affinity transporter allows re-uptake
of choline (Fig 2D) back to the nerve terminals from
which the ACh was released. For ACh, an additional
enzyme is needed to chemically recover the NT from its
precursors. This is achieved by a single step reaction car-
ried out by the enzyme Choline acetyltransferase (ChAT)
(Fig 2E). The full recovery of the release capacity is still
dependent on an additional SV transporter whose func-
tion is to efficiently pack the NT into SVs (VAChT) (Fig
2F). The transmission capacity is then restored, and the
synapse is ready for an additional cycle.
How does a neuron, which is characterized by a unique
NT phenotype, coordinate the expression of the many
proteins which are essential for its identity? The question
of gene expression coordination is of course central in any
biological complex system. A tight control on the amount
of NT production, storage, release and uptake is main-
tained for each synapse. Herein, we discuss one of the
strategies for coordinated gene expression. Our discussion
is limited to the cholinergic synapse. Specifically, we focus
on two key proteins: (i) the enzyme that produces ACh
(called ChAT) and (ii) the transporter responsible to store
ACh (called VAChT) in SVs (marked as E, F in Fig. 2).
Based on genomic organization studies in the mouse
genome, it was shown that the transporter VAChT is
located within the first non-coding intron of the gene for
ChAT [33]. The latter has several functional splice variants
and multiple promoters [34]. Instances of functionally
related genes that are located at the same chromosomal
site are known primarily in bacterial genomes. Still this
phenomenon of VAChT-ChAT arrangement is referred to
as the 'cholinergic locus'. The genomic structure in Dro-
sophila and C. elegans shows a highly conserved organiza-
tion, where the VAChT is expressed with a common non-
coding exon and the coding region of it is a single exon
that is completely embedded within the ChAT intron [33].
Interestingly, in all these organisms, a sequence of about
2500 nucleotides preceding the VAChT coding region has
been shown to recruit a specific silencer and also to con-
tain a stable RNA folded structure [35]. The tools of the
genomic browser [36] allow tracking regions of high
sequence conservation without a priori knowledge on
functional importance. Inspecting the cholinergic locus
region shows that the conservation level for a 2500 nt
sequence at the vicinity of the ChAT transcripts is very
high (higher than for the coding exons of ChAT, marked
as orange empty boxes, Fig. 3). It is expected that some
general rules concerning the functional relevance of 'con-
served' sequences can be extracted.
The coordination in expression of the cholinergic locus
genes is based on their physical gene organization. For
other NT phenotypes, alternative mechanism for gene
expression coordination is applied. For example, inPage 4 of 9
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a complete coordination between the GABA synthesis
enzyme (GAD) and the vesicular GABA transporter is
achieved through a shared transcription factor [37].
From a computational perspective, a natural question is to
what level the mechanism of 'cholinergic locus' has been
duplicated in other context of gene coordination. In more
general terms, hidden information in non-coding regions
is far richer than previously anticipated. Bearing in mind
the phenomenon described above, the presence of small
non-coding RNAs and short antisense sequences, a simple
assignment of sequences as non-coding should be revised.
This fact is in particular critical for the application of
machine learning approaches to predict intron-exon
boundaries and more recently in the prediction of alterna-
tive splicing.
C. The Dendritic Factory
Short-term memory in the neuron is executed by modifi-
cation of already present transcripts and proteins [38].
However, long-lasting forms of memory require macro-
molecular synthesis [39]. Can long-term memory changes
and protein synthesis be demonstrated in only a subset of
the synapses in cells that may have thousands of active
synapses? To address this question, we should consider
the neuronal anatomy. Indeed, expression of specific
genes in dendrites is an intriguing idea that can explain
specification and variation at the level of individual syn-
apses. The distance of the cell body and the functional
A schematic view of an ACh synapseFigur  2
A schematic view of an ACh synapse. Molecules that specify the NT phenotype are marked A-F. A, a representative of ACh lig-
and binding receptor family; B, muscarinic ACh receptor as presynaptic autoinhibitors; C, Acetylcolinesterase, AchE; D, 
Choline high affinity transporter; E, Choline Acetyle Transferase, ChAT; F, Vesicular ACh transporter, VAChT. E and F pro-
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BMC Bioinformatics 2006, 7:S6identity of different domains of the dendritic tree make it
unlikely that the protein repertoire is determined by the
cell body. In contrast, protein translation at a select den-
drite would allow a fast and flexible response to local
stimuli [40-42]. This would allow a long-term plasticity at
a given synaptic site, in response to changing conditions.
For key reviews see [43-47].
The attractive idea of dendritic protein translation is sup-
ported by evidence on ribosomes' presence at synaptic
junctions of dendrites. A search for RNA at these sites,
mostly using in-situ hybridization and amplification tech-
niques, detected several tens of specific mRNA in addition
to abundant non-coding RNA of the translation machin-
ery, i.e., rRNA and tRNA [48,49]. Later studies established
that not only ribosomes but the endoplasmic reticulum
and Golgi elements are present in dendrites. In addition,
processes of posttranslational modification (i.e phospho-
rylation) and of membrane insertion were confirmed
[50]. A direct illustration of the ability of the dendrite to
drive protein translation is based on injecting test mRNAs
to dendrites, and monitoring the expressed encoded pro-
tein. The subset of RNAs that was shown to accumulate in
the synaptic junctions of dendrites includes proteins that
were implicated in morphological and functional remod-
eling of the synapse. Examples are kinases, ion channels
and receptors, cytoskeletal elements and proteins
involved in trafficking and sorting. Interestingly, some of
these selectively delivered RNA that are located in den-
drites, become capable of being translated only following
A visualization and annotation of a genomic region in the vicinity of the 'cholinergic locus' at chromosome 10 (in human)Figure 3
A visualization and annotation of a genomic region in the vicinity of the 'cholinergic locus' at chromosome 10 (in human). For 
more information on the visualization, see [36]. Orange lined boxes mark the exons of the ChAT and several of the alternative 
transcripts. The orange bar indicates the entire length of the first ChAT non-coding exon. The level of conservation among 
Human-Mouse-Chimp-Rat-Dog-Chicken-Fugu and Zebrafish is shown graphically by the height of the conservation histogram. 
The pairwise conservation with human is depicted by the scale from black (high) to low (white) for each of the listed organ-
isms. Note that the level of conservation in human-mouse-rat-Fugu extends beyond the coding region of VAChT (semi-trans-
parent orange box).
1st ChAT non-coding axon;  
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bining all those observations, one concludes that only
stimulated synapses will undergo structural and func-
tional changes that are associated with synaptic plasticity.
Several experiments combining a biochemical purifica-
tion step followed by PCR-based amplification were per-
formed to resolve the full repertoire of RNAs that can be
transported to dendritic sites. The conclusion from these
experiments is that the repertoire of RNA that is trans-
ported to dendrites is larger than was initially assumed.
The most extensive survey using a sensitive PCR based
technology argues that ~400 different mRNA (about 5%
of the total active transcripts in these neurons) are local-
ized to the dendrites [50]. A more sensitive screening tech-
nique suggested a lower bound of 10–15% of the
transcripts as potential candidates for translation regula-
tion [53].
Many unsolved questions remain: (i) What are the shared
features (in terms of sequence/structure) of the cis-acting
elements that allow RNA molecules to be transported to
dendrites? (ii) What is the nature of the repression of RNA
that keeps it dormant, allowing it to be activated only fol-
lowing stimulation? (iii) What is the molecular basis for
the motor-based delivery of the set of selected RNA?
Some interesting observations from the study of mamma-
lian Staufen (Stau) protein [54] shed light on the traffick-
ing step. Stau is a double-stranded RNA (dsRNA)-binding
protein that also contains a microtubule (MT)-binding
domain. Thus, Stau may form cross-links between the MT
cytoskeletal tracks and RNA components. Despite detailed
studies on specific test cases of dendritic RNA, the mecha-
nism for delivering only a subset of RNA to dendrites is
not yet fully resolved [55]. It is believed that information
encoded in the 3' UTR (untranslated region) of the RNA
provide the essential sequence and structure information
[56]. Indeed, several of the RNAs known to be delivered to
dendrites share a short consensus sequence (called A2RE).
Binding of the trans-acting factor (hnRNP-A2) to these
sequences will initiate trafficking to dendrites. Further-
more, only RNAs that contain these A2RE-like sequences
are assembled into mRNA granules [57]. Those granules
contain elements of the translation machinery and the
essential MT-based motors. We are still lacking an exhaus-
tive sequence and structure based comparison for hun-
dreds of transported RNAs. Application of feature
selection tools and machine learning technologies would
help characterize the dendritic transporting specificity.
Once the RNA is delivered to the dendrite, it is kept in a
repressed conformation. Only following stimulation, the
repression is relieved [42,43]. Understanding the
sequence of events that lead to activity-dependent relief
from the translation arrest is critical to cellular events
where regulation at the level of translation dominates. Key
players in this switch are a set of activity-dependent
kinases that can cause the dormant RNA to undergo a
sequential set of changes. The challenge is to build a 'sys-
tems-level' model of these events by monitoring the quan-
tities and the states (i.e. phosphorylation) of each of the
proteins involved.
Answers to these open questions will be based on devel-
oping technologies that allow large scale observations:
(i) Imaging techniques
By improving the spatial resolution at the neuronal level
and monitoring time dependent distribution of essential
proteins following activation, one can hope to distinguish
between alternative hypotheses for synaptic plasticity.
(ii) Proteomic screening
A pull-down proteomic survey using one of the compo-
nents of the mRNA granule allows an unbiased identifica-
tion of all other components and their composition
within the mRNA granules that are delivered to dendrites
[58]. Using this approach, it was confirmed that the
mRNA granules are composed of tens of proteins includ-
ing ribosomes, components of the translational machin-
ery as well as several mRNA-binding proteins.
Computationally, this requires improving the quality and
accuracy of mass spectroscopy based technologies.
(iii) A genomic screen
An additional proposed regulatory mechanism for con-
trolling localized translation in neurons is by non-coding
RNA. An example is the non-coding dendritic RNA BC1
[59] and micro-RNAs (miRNAs) [60]. Tens of comple-
mentary sequences in the 3' UTR of target mRNAs were
shown to match miRNAs that were associated with polyr-
ibosomes in brain extract. A systematic computational
survey to characterize the features of the many confirmed
miRNAs and to predict others is still missing.
Summary and future perspectives
We have presented several issues that are critical for the
functionality of the synapse – axonal transport, molecular
based plasticity and coordination in gene expression.
Those examples were selected to indicate that additional
experimental and computational research is needed to
fully appreciate the mechanisms that are used by the neu-
rons to maintain their functional properties. Powered by
genomics, proteomics and bioinformatics, combined
with classical neuroscience research, will not only be the
basis for constructing accurate simulation of a functioning
synapse, but also of a functional neuronal circuit in the
brain.Page 7 of 9
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